TY  - GEN
AU  - Abedi,Farshad
AU  - Wickremasinghe,Sanjeewa
AU  - Richardson,Andrea J
AU  - Islam,Amirul F M
AU  - Guymer,Robyn H
AU  - Baird,Paul N
TI  - Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration
SN  - 1549-4713
PY  - 2013///1106
KW  - Aged
KW  - Aged, 80 and over
KW  - Angiogenesis Inhibitors
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Humanized
KW  - Bevacizumab
KW  - Cohort Studies
KW  - Complement C3b Inactivator Proteins
KW  - genetics
KW  - Complement Factor H
KW  - Complement System Proteins
KW  - Female
KW  - Genotype
KW  - High-Temperature Requirement A Serine Peptidase 1
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Pharmacogenetics
KW  - Polymorphism, Single Nucleotide
KW  - Prospective Studies
KW  - Proteins
KW  - Ranibizumab
KW  - Retreatment
KW  - Serine Endopeptidases
KW  - Treatment Outcome
KW  - Vascular Endothelial Growth Factor A
KW  - antagonists & inhibitors
KW  - Visual Acuity
KW  - physiology
KW  - Wet Macular Degeneration
KW  - drug therapy
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ophtha.2013.01.014
ER  -